CHEGG SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Chegg, Inc. - CHGG
NEW ORLEANS, Jan. 14, 2022 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 22, 2022 to file lead plaintiff applications in a securities class action lawsuit against Chegg, Inc. (NYSE: CHGG), if they purchased the Company’s shares between May 5, 2020 and November 1, 2021, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.
Chegg investors should visit us at https://claimsfiler.com/cases/nyse-chgg or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.
About the Lawsuit
Chegg and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On November 1, 2021, the Company announced its third quarter financial results, the first quarter in which students returned to campus across the United States, disclosing fewer than expected online enrollments due to the Covid-19 pandemic and failed to provide guidance for 2022.
On this news, shares of Chegg fell nearly 50%.
The case is Leventhal v. Chegg, Inc., No. 21-cv-09953.
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.
To learn more about ClaimsFiler, visit www.claimsfiler.com.